Total Payments
$34,800
2024 Payments
$917.62
Companies
43
Transactions
630
Medicare Patients
4,612
Medicare Billing
$507,928
Payment Breakdown by Category
Other$24,844 (71.4%)
Food & Beverage$9,165 (26.3%)
Consulting$484.00 (1.4%)
Travel$277.46 (0.8%)
Education$29.04 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,400 | 16 | 61.5% |
| Food and Beverage | $9,165 | 600 | 26.3% |
| Honoraria | $3,444 | 5 | 9.9% |
| Consulting Fee | $484.00 | 2 | 1.4% |
| Travel and Lodging | $277.46 | 4 | 0.8% |
| Education | $29.04 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $14,238 | 87 | $0 (2020) |
| ABBVIE INC. | $10,826 | 218 | $0 (2024) |
| Aries Pharmaceuticals, Inc. | $4,222 | 11 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $846.90 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $829.01 | 45 | $0 (2024) |
| Boston Scientific Corporation | $375.10 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $355.47 | 20 | $0 (2024) |
| QOL Medical, LLC | $339.49 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $337.83 | 20 | $0 (2024) |
| GENZYME CORPORATION | $195.39 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $917.62 | 41 | ABBVIE INC. ($227.91) |
| 2023 | $6,560 | 75 | ABBVIE INC. ($6,020) |
| 2022 | $3,834 | 93 | ABBVIE INC. ($2,875) |
| 2021 | $1,446 | 77 | AbbVie Inc. ($616.02) |
| 2020 | $3,529 | 50 | Allergan, Inc. ($2,842) |
| 2019 | $4,468 | 97 | Allergan Inc. ($3,331) |
| 2018 | $2,992 | 91 | Aries Pharmaceuticals, Inc. ($1,665) |
| 2017 | $11,054 | 106 | Allergan Inc. ($7,703) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $112.53 | General |
| Category: Rare Disease | ||||||
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.62 | General |
| Category: Neuroscience | ||||||
| 05/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.71 | General |
| 04/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $131.49 | General |
| Category: General - Biliary Devices_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,041 | 1,158 | $440,278 | $111,795 |
| 2022 | 15 | 1,073 | 1,197 | $435,376 | $119,530 |
| 2021 | 20 | 1,425 | 1,681 | $568,577 | $160,973 |
| 2020 | 18 | 1,073 | 1,233 | $431,031 | $115,630 |
Total Patients
4,612
Total Services
5,269
Medicare Billing
$507,928
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 253 | $43,010 | $23,867 | 55.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 91 | 92 | $78,200 | $18,482 | 23.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 241 | 270 | $116,100 | $16,408 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 207 | $26,910 | $13,258 | 49.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 79 | 79 | $50,639 | $8,310 | 16.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 65 | 69 | $34,776 | $7,491 | 21.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 44 | 44 | $25,203 | $7,434 | 29.5% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 28 | 28 | $19,460 | $3,866 | 19.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $9,100 | $3,772 | 41.5% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 12 | 12 | $16,560 | $2,602 | 15.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $9,192 | $1,970 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 31 | $3,875 | $1,905 | 49.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $5,634 | $1,684 | 29.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,620 | $744.96 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 308 | $52,360 | $28,915 | 55.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 75 | 75 | $63,750 | $14,599 | 22.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 221 | 237 | $101,910 | $14,271 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 193 | $25,090 | $13,015 | 51.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 95 | 95 | $60,895 | $10,845 | 17.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 58 | 61 | $30,744 | $6,842 | 22.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 38 | 39 | $23,127 | $6,703 | 29.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 14 | 29 | $14,355 | $6,028 | 42.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $15,418 | $3,722 | 24.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $6,875 | $3,571 | 51.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $11,267 | $3,349 | 29.7% |
About Dr. Chetan Pai, D.O
Dr. Chetan Pai, D.O is a Gastroenterology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649488230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chetan Pai, D.O has received a total of $34,800 in payments from pharmaceutical and medical device companies, with $917.62 received in 2024. These payments were reported across 630 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,400).
As a Medicare-enrolled provider, Pai has provided services to 4,612 Medicare beneficiaries, totaling 5,269 services with total Medicare billing of $507,928. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Fredericksburg, VA
- Active Since 05/18/2007
- Last Updated 03/16/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649488230
Products in Payments
- LINZESS (Drug) $22,191
- ELEVIEW (Device) $4,222
- HUMIRA (Biological) $821.90
- XIFAXAN (Drug) $654.83
- Humira (Biological) $538.36
- ENTYVIO (Biological) $441.57
- RINVOQ (Biological) $403.91
- CREON (Drug) $366.30
- VIBERZI (Drug) $269.24
- DUPIXENT (Biological) $256.10
- STELARA (Biological) $219.73
- Sucraid (Drug) $192.21
- Amitiza (Drug) $190.22
- SKYRIZI (Biological) $177.92
- Entyvio (Biological) $177.73
- Linzess (Drug) $175.78
- ZENPEP (Drug) $167.40
- GATTEX (Drug) $165.40
- SUCRAID (Drug) $147.28
- Creon (Drug) $140.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fredericksburg
Dr. Christopher Fincke, M.d, M.D
Gastroenterology — Payments: $63,127
Gastroenterology $63,127
Narayan Dharel, Md, Phd, MD, PHD
Gastroenterology — Payments: $49,311
Gastroenterology $49,311
Dr. Frank Detrane, M.d, M.D
Gastroenterology — Payments: $8,733
Gastroenterology $8,733
Dr. Peter Wong, M.d, M.D
Gastroenterology — Payments: $7,926
Gastroenterology $7,926
Dr. Dong Lee, M.d, M.D
Gastroenterology — Payments: $7,102
Gastroenterology $7,102
Farrukh Jafri, M.d, M.D
Gastroenterology — Payments: $6,170
Gastroenterology $6,170